MA44850A - Composition ophtalmique comprenant une combinaison synergique de glycogène et d'acide hyaluronique ou d'un sel de celui-ci - Google Patents

Composition ophtalmique comprenant une combinaison synergique de glycogène et d'acide hyaluronique ou d'un sel de celui-ci

Info

Publication number
MA44850A
MA44850A MA044850A MA44850A MA44850A MA 44850 A MA44850 A MA 44850A MA 044850 A MA044850 A MA 044850A MA 44850 A MA44850 A MA 44850A MA 44850 A MA44850 A MA 44850A
Authority
MA
Morocco
Prior art keywords
glycogen
salt
same
hyaluronic acid
composition including
Prior art date
Application number
MA044850A
Other languages
English (en)
Inventor
Elisa Liberati
Lorella Ragni
Vincenzo Russo
Giuseppe Santo
Serena Tongiani
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of MA44850A publication Critical patent/MA44850A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA044850A 2016-05-05 2017-04-28 Composition ophtalmique comprenant une combinaison synergique de glycogène et d'acide hyaluronique ou d'un sel de celui-ci MA44850A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16168464 2016-05-05

Publications (1)

Publication Number Publication Date
MA44850A true MA44850A (fr) 2021-04-28

Family

ID=55919680

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044850A MA44850A (fr) 2016-05-05 2017-04-28 Composition ophtalmique comprenant une combinaison synergique de glycogène et d'acide hyaluronique ou d'un sel de celui-ci

Country Status (16)

Country Link
US (1) US20190151352A1 (fr)
EP (1) EP3452010A1 (fr)
JP (1) JP2019514887A (fr)
KR (1) KR20190004275A (fr)
CN (1) CN109152730A (fr)
AR (1) AR108280A1 (fr)
AU (1) AU2017260839A1 (fr)
BR (1) BR112018071173A2 (fr)
CA (1) CA3018619A1 (fr)
EA (1) EA201892389A1 (fr)
GE (2) GEP20207144B (fr)
IL (1) IL262573A (fr)
MA (1) MA44850A (fr)
MX (1) MX2018012952A (fr)
SG (1) SG11201808245XA (fr)
WO (1) WO2017191041A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110179748B (zh) * 2019-06-25 2021-08-10 吉林省华恩生物科技有限公司 一种缓解眼部炎症及过敏症状滴眼液及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255488B (it) 1992-08-04 1995-11-06 Angelini Francesco Ist Ricerca Polisaccaridi del glicogeno
IT1273011B (it) * 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
EP1004307B1 (fr) * 1998-01-30 2002-09-04 R-Tech Ueno, Ltd. Composition ophtalmique
IT1298758B1 (it) 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
JP2001089381A (ja) * 1999-09-16 2001-04-03 Taisho Pharmaceut Co Ltd 皮膚外用剤
DE60209144T2 (de) * 2001-12-21 2006-08-17 Alcon Inc. Viskoelastische ophthalmische zubereitungen enthaltend hyaluronsäure und chondroitinsulfat
US7670812B2 (en) 2004-09-30 2010-03-02 Ezaki Glico Co., Ltd. Method of producing glycogen
WO2008001872A1 (fr) * 2006-06-28 2008-01-03 Rohto Pharmaceutical Co., Ltd. Composition ophthalmique contenant de l'acide alginique ou un sel de celui-ci
EP2070518A2 (fr) * 2006-07-25 2009-06-17 Osmotica Corp. Solutions ophtalmiques
ITRM20070510A1 (it) * 2007-10-02 2009-04-03 Rmfa Trading S A Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
PT2240154E (pt) * 2008-02-01 2014-05-27 Acraf Composição cosmética compreendendo glicogénio para aplicação na pele para efeito de veludo
CN102065869B (zh) * 2008-07-01 2014-10-08 玛丽诺姆德生物技术公司 抗过敏的海洋生物聚合物
US8283463B2 (en) 2010-02-09 2012-10-09 Bausch & Lomb Incorporated Sterile hyaluronic acid solutions
US9089677B2 (en) * 2011-01-25 2015-07-28 The Regents Of The University Of California Transcutaneous multimodal delivery system (TMDS)
MX366228B (es) * 2011-03-25 2019-07-03 Selecta Biosciences Inc Nanoportadores sinteticos de liberacion mediada por osmosis.

Also Published As

Publication number Publication date
GEAP202014947A (en) 2020-04-10
AU2017260839A1 (en) 2018-10-11
IL262573A (en) 2018-12-31
GEP20207144B (en) 2020-08-10
MX2018012952A (es) 2019-01-21
SG11201808245XA (en) 2018-11-29
US20190151352A1 (en) 2019-05-23
CN109152730A (zh) 2019-01-04
CA3018619A1 (fr) 2017-11-09
EA201892389A1 (ru) 2019-04-30
AR108280A1 (es) 2018-08-08
BR112018071173A2 (pt) 2019-02-05
EP3452010A1 (fr) 2019-03-13
JP2019514887A (ja) 2019-06-06
WO2017191041A1 (fr) 2017-11-09
KR20190004275A (ko) 2019-01-11

Similar Documents

Publication Publication Date Title
FR25C1001I2 (fr) Compositions d'anticorps pour le traitement de tumeurs
HUE069999T2 (hu) Kompozíció miópia megelõzésében vagy szuppressziójában történõ alkalmazásra
MA53243A (fr) Compositions comprenant une combinaison de ipilimumab et nivolumab
EP3362946A4 (fr) Identification de la position de l'oeil à l'aide de caractéristiques de l'oeil
MA71266A (fr) Procédés d'intervention précoce pour prévenir ou améliorer la toxicité
PT3500255T (pt) Composições farmacêuticas oftálmicas e utilizações relacionadas com estas
EP3621656A4 (fr) Formulation pour l'administration d'un médicament pour les yeux
EP3413928A4 (fr) Agents thérapeutiques à base de micro-arn anti-angiogéniques pour l'inhibition de la néovascularisation cornéenne
EP3725780A4 (fr) Dérivé de sulfonamide ou sel d'addition d'acide pharmaceutiquement acceptable
EP3412292A4 (fr) Utilisation de méthoxatine, d'un dérivé et/ou d'un sel de cette dernière contre le syndrome de gougerot-sjögren, et composition pharmaceutique
EP3634426A4 (fr) Compositions pour le traitement d'une fibrose
DK3720433T3 (da) Bis-cholin-tetrathiomolybdat til behandling af wilsons sygdom
MA41689A (fr) Prévention ou traitement de troubles du sommeil au moyen d'une formulation de dexmédétomidine
MA46621A (fr) Traitements combinés comprenant l'administration d'imidazopyrazinones
FR3052071B1 (fr) Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon et un co-polyaminoacide
MA41120A (fr) Compositions comprenant le 15-hepe et méthodes de traitement ou de prévention de la fibrose à l'aide de celles-ci
CY1127309T1 (el) Ebselen για χρηση στη θεραπεια της νοσου meniep
EP3733177A4 (fr) Composition pour la protection de la cornée
EP3329929A4 (fr) Composition pharmaceutique pour la prévention ou le traitement de la sécheresse oculaire
EP3423060A4 (fr) Imatinib utilisable dans le traitement d'une attaque
EP2968328A4 (fr) Compositions destinées à être utilisées en traitement de troubles oculaires à l'aide de dipyridamole
EP3668991A4 (fr) Nanosupports pour l'administration de principes actifs
EP3632430A4 (fr) Agent de prévention ou de traitement de l'ataxie spinocérébelleuse
BR112018000568A2 (pt) antagonistas do receptor 5-ht6 para uso no tratamento da doença de alzheimer com apatia como comorbidade
SI3413870T1 (sl) Igmezin za uporabo pri zdravljenju alzheimerjeve bolezni